Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Listen to expert discussions and interviews in pharma and biopharma.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
New name follows management shift, expansion
July 15, 2011
By: Gil Roth
President, Pharma & Biopharma Outsourcing Association
Harmony Labs has changed its name to Ei and announced its new industry classification: A Pharmaceutical SolutionWorks. “We’ve created a new name and classification for what we do to reflect the dramatic shift in the way we provide value to our customers. We bring the best development and manufacturing practices and a high-level understanding of branding into outsourced manufacturing. For the right company, we offer a partnership they just can’t get anywhere else,” said Michael Kane, chief executive officer. The name Ei is derived from the chemical concept of ionic bonding. “It is also an analogous explanation of what the company has become: Ei uses state-of-the-art science and manufacturing in the creation of products, but also forms unparalleled bonds with their partnering companies, helping them to move their brands forward,” according to a company statement. This approach “moves far beyond the definition of a traditional Contract Manufacturing Organization, and instead focuses on bringing solutions to customers, and above all, protecting their brands.” Ei can be found at www.eisolutionworks.com. In 2009-2010, Harmony Labs established a new management team behind Mr. Kane, with industry experts in manufacturing, formulation, regulatory, sales and human resources. The management team averages more than 20 years of experience in their given fields and has been successful building capabilities in top-tier pharmaceutical and consumer packaged goods companies, according to a company statement. In addition, the company constructed and opened a brand new 165,000-sq.-ft. manufacturing facility, adding the ability to produce NDA and ANDA products. Comprehensive testing and development labs were added, and best-in-class systems for safety, R&D, formulation, operations and project management were implemented.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !